Abstract

Feasibility Study of Erlotinib (tarceva R) Plus Radiotherapy in Patients with Locally Advanced or Recurrent Rectal Carcinoma

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call